[Alizapride in the treatment of vomiting induced by cytostatic agents].
Most antineoplastic agents, particularly cisplatinum, cause nausea and vomiting. In an open study, 30 subjects receiving anticancer drugs were given the antiemetic Alizapride. The incidence of severe nausea was reduced from 50% to 24% on day 3. The percentage of patients without vomiting was raised to 77% until day 5. These results are in line with those of other clinical studies on Alizapride.
D000818:Animals; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D006801:Humans; D008297:Male; D011759:Pyrrolidines / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D011759:Pyrrolidines; C033968:alizapride
Alizaprid in der Behandlung des durch Zytostatika bedingten Erbrechens.